KOSDAQ-Listed Bio Firm Under Review for Unfaithful Disclosure

A bio firm listed on the KOSDAQ exchange is set to undergo a review due to unfaithful disclosure practices. This action highlights regulatory scrutiny over corporate transparency in South Korea's stock market.